Reflection Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$237K Hold
454
– – 0.1% 135
2026
Q2
$226K Buy
+454
New +$201K 0.11% 140
2026
Q1
– Sell
-288
Closed -$131K – 474
2025
Q4
$131K Buy
+288
New +$124K 0.09% 131

Other funds holding VRTX

Reflection Asset Management's VRTX Position: Q3 2026 in Review

Reflection Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 454 shares worth $237K. The position accounts for 0.1% of the portfolio, ranked #135.

Reflection Asset Management first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,793 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Reflection Asset Management held 454 shares of Vertex Pharmaceuticals worth $237K as of Q3 2026.
  • Reflection Asset Management left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
  • Vertex Pharmaceuticals made up 0.1% of Reflection Asset Management's portfolio in Q3 2026, its #135 holding.
  • Reflection Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 1,793 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Reflection Asset Management's 13F filing for Q3 2026, filed 28 Oct 2026.